PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10285677

Technology on wheels: evaluating the options.

View original source ↗Export metadata ↓

Abstract

Housing costly technology in a mobile unit may promote flexibility in where and how it is used. Mobile technology allows hospitals and physician groups to provide services that they might not be able to offer otherwise. Joint ventures with mobile technology bring both services to communities and patients to support those services. Mobile units harbor a range of complex procedures, but the road to using them in an appropriate and cost-effective manner can present unexpected twists and turns.

Explore related subjects

Capital ExpendituresCardiac CatheterizationDecision MakingHospital Shared ServicesLithotripsyMagnetic Resonance ImagingMammographyMobile Health UnitsOwnershipTechnology Assessment, BiomedicalTomography, X-Ray ComputedUnited StatesJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Technology on wheels: evaluating the options.. https://pubmed.ncbi.nlm.nih.gov/10285677/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

The price of innovation: new estimates of drug development costs.

The research and development costs of 68 randomly selected new drugs were obtained from a survey of 10 pharmaceutical firms. These data were used to estimate the average pre-tax cost of new drug development. The costs of compounds abandoned during testing were linked to the costs of compounds that obtained marketing approval. The estimated average out-of-pocket cost per new drug is 403 million US dollars (2000 dollars). Capitalizing out-of-pocket costs to the point of marketing approval at a real discount rate of 11% yields a total pre-approval cost estimate of 802 million US dollars (2000 dollars). When compared to the results of an earlier study with a similar methodology, total capitalized costs were shown to have increased at an annual rate of 7.4% above general price inflation.

Capital Expenditures↗